3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Gastrointestinal
1
Conditions
cyclopia sequence
14
Lung Neoplasms
4
Multiple Myeloma
3
Head and Neck Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
3
Pain
2
Neoplasms, Plasma Cell
2
Wilms Tumor
1
Waldenstrom Macroglobulinemia
1
Thromboembolism
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Spinal Cord Neoplasms
1
Sleepiness
1
Sezary Syndrome
1
Sarcoma
1
Recurrence
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Postoperative Cognitive Complications
1
Peripheral Nervous System Diseases
1
Peptic Ulcer
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Parasomnias
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Interventions
Docetaxel
171
Radiotherapy
144
Magnetic Resonance Spectroscopy
142
Leuprolide
112
Prednisone
108
enzalutamide
102
Radiosurgery
101
Abiraterone Acetate
94
Androgen Antagonists
91
Goserelin
83
bicalutamide
81
gallium 68 PSMA-11
70
Surveys and Questionnaires
63
apalutamide
57
Specimen Handling
56
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
55
Radiation
47
Gonadotropin-Releasing Hormone
45
Standard of Care
44
Biopsy
44
Brachytherapy
42
Radiotherapy, Intensity-Modulated
40
Blood Specimen Collection
40
darolutamide
39
abiraterone
39
cabazitaxel
35
Exercise
35
Carboplatin
33
Pluvicto
32
Triptorelin Pamoate
31
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Prostatic Neoplasms
×
Minocycline
×
Clear all
NCT02928692
2020-01-28
MAPOCD
RenJi Hospital
Phase 3
Unknown
750 enrolled